BrightPath Biotherapeutics Investors
BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies.
Industry:
Advanced and Next Generation Therapies (Various)
Headquarters:
Kurume, Fukuoka, Japan
Technology:
Advanced Longevity (R&D)
Founded Date:
2003